Our discovery that modulation of the Wnt/β-catenin signaling pathway via the miR-134/ITGB1 axis resulted in a drastic reduction in distant metastasis, suggested that therapeutic targeting of the Wnt/β-catenin pathway is likely a promising approach for controlling NPC metastasis. The gene discussed is ITGB1; the disease is nasopharyngeal carcinoma.